Uroselective Alpha-1-Antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery

Abroad (travel likely)RecruitingPHASE4

Conditions

Urinary Retention Postoperative

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Mayo Clinic in Rochester, Rochester, Minnesota, United States

    Contact: Study coordinator (Neurologic Surgery Research Team) · 507-422-5673
    Contact: Principal Investigator (Michelle J Clarke, MD, PhD)
Study leads
  • Michelle Clarke, MD, PhD

    Principal Investigator

    Mayo Clinic